Egetis Therapeutics AB (publ) Cash Flow Quality Index

Latest as of March 2019: 1.22x

Egetis Therapeutics AB (publ) cash flow quality index. Egetis Therapeutics AB (publ) (EGTX) has a Cash Flow Quality Index of 1.22x as of March 2019. Operating cash flow of Skr28.02 Million exceeds net income of Skr22.89 Million, indicating high earnings quality where cash backs reported profits. See EGTX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.22x
Operating CF / Net Income

Operating Cash Flow

Skr28.02 Million
SEK

Net Income

Skr22.89 Million
SEK

Data as of

Mar 2019
Most recent filing

Egetis Therapeutics AB (publ) Cash Flow Quality Index by Year (None–None)

Egetis Therapeutics AB (publ) cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Egetis Therapeutics AB (publ). For the full cash flow conversion analysis, see Egetis Therapeutics AB (publ) (EGTX) cash flow conversion.

Year Quality Index Operating CF (SEK) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.